Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31935 | 146 | 83.2 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
563 | 3 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
382 | 2 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
31935 | 1 | DIETARY COMPOUNDS//MIR 1260B//3 UTR LUCIFERASE ASSAY | 146 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIETARY COMPOUNDS | authKW | 313718 | 2% | 50% | 3 |
2 | MIR 1260B | authKW | 278862 | 1% | 67% | 2 |
3 | 3 UTR LUCIFERASE ASSAY | authKW | 209147 | 1% | 100% | 1 |
4 | BIOL AD TAT AGING B2A | address | 209147 | 1% | 100% | 1 |
5 | BREAST CANCER SUSCEPTIBILITY GENES 1 AND 2 | authKW | 209147 | 1% | 100% | 1 |
6 | CARDIOVASC MAASTRICT CARIM | address | 209147 | 1% | 100% | 1 |
7 | CELL MOL SCI NUTR | address | 209147 | 1% | 100% | 1 |
8 | COSMECEUTICAL ACTIVE INGREDIENTS | authKW | 209147 | 1% | 100% | 1 |
9 | COSMECEUTICAL DELIVERY TECHNOLOGIES | authKW | 209147 | 1% | 100% | 1 |
10 | DIRECTOR EPIGENET CANC PREVENT | address | 209147 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Nutrition & Dietetics | 588 | 17% | 0% | 25 |
2 | Oncology | 561 | 33% | 0% | 48 |
3 | Genetics & Heredity | 92 | 12% | 0% | 17 |
4 | Toxicology | 76 | 8% | 0% | 11 |
5 | Pharmacology & Pharmacy | 63 | 14% | 0% | 21 |
6 | Biochemistry & Molecular Biology | 40 | 18% | 0% | 26 |
7 | Chemistry, Medicinal | 27 | 5% | 0% | 7 |
8 | Cell Biology | 27 | 9% | 0% | 13 |
9 | Medicine, Research & Experimental | 9 | 4% | 0% | 6 |
10 | Biology | 7 | 3% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOL AD TAT AGING B2A | 209147 | 1% | 100% | 1 |
2 | CARDIOVASC MAASTRICT CARIM | 209147 | 1% | 100% | 1 |
3 | CELL MOL SCI NUTR | 209147 | 1% | 100% | 1 |
4 | DIRECTOR EPIGENET CANC PREVENT | 209147 | 1% | 100% | 1 |
5 | EA4233 NUTR CARCINOGENESIS ANTITUMOR THER Y | 209147 | 1% | 100% | 1 |
6 | HAEMATOL UNION HOSP | 209147 | 1% | 100% | 1 |
7 | INRAUNHCRNH AUVERGNEUMR1019 | 209147 | 1% | 100% | 1 |
8 | INVEST CANC TER IA CELULAR | 209147 | 1% | 100% | 1 |
9 | LIPID SIGNALING LIPID VASCULOTOX PHARM | 209147 | 1% | 100% | 1 |
10 | NUTR FOOD HYG MIL PREVENT MED | 209147 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPIGENOMICS | 7235 | 3% | 1% | 4 |
2 | EPIGENETICS | 3264 | 1% | 1% | 2 |
3 | CLINICAL EPIGENETICS | 2057 | 1% | 0% | 2 |
4 | ADVANCES IN NUTRITION | 1827 | 1% | 0% | 2 |
5 | AAPS JOURNAL | 1660 | 2% | 0% | 3 |
6 | NUTRIENTS | 1417 | 3% | 0% | 4 |
7 | JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS | 1122 | 1% | 1% | 1 |
8 | JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS | 1054 | 1% | 1% | 1 |
9 | NUTRITION REVIEWS | 1021 | 3% | 0% | 4 |
10 | CURRENT CANCER DRUG TARGETS | 877 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PUDENZ, M , ROTH, K , GERHAUSER, C , (2014) IMPACT OF SOY ISOFLAVONES ON THE EPIGENOME IN CANCER PREVENTION.NUTRIENTS. VOL. 6. ISSUE 10. P. 4218 -4272 | 35 | 24% | 9 |
2 | GERHAUSER, C , (2013) CANCER CHEMOPREVENTION AND NUTRI-EPIGENETICS: STATE OF THE ART AND FUTURE CHALLENGES.NATURAL PRODUCTS IN CANCER PREVENTION AND THERAPY. VOL. 329. ISSUE . P. 73-132 | 39 | 15% | 51 |
3 | SHUKLA, S , MEERAN, SM , KATIYAR, SK , (2014) EPIGENETIC REGULATION BY SELECTED DIETARY PHYTOCHEMICALS IN CANCER CHEMOPREVENTION.CANCER LETTERS. VOL. 355. ISSUE 1. P. 9 -17 | 23 | 23% | 24 |
4 | THAKUR, VS , DEB, G , BABCOOK, MA , GUPTA, S , (2014) PLANT PHYTOCHEMICALS AS EPIGENETIC MODULATORS: ROLE IN CANCER CHEMOPREVENTION.AAPS JOURNAL. VOL. 16. ISSUE 1. P. 151-163 | 21 | 22% | 17 |
5 | SCHNEKENBURGER, M , DICATO, M , DIEDERICH, M , (2014) PLANT-DERIVED EPIGENETIC MODULATORS FOR CANCER TREATMENT AND PREVENTION.BIOTECHNOLOGY ADVANCES. VOL. 32. ISSUE 6. P. 1123 -1132 | 22 | 18% | 14 |
6 | AGGARWAL, R , JHA, M , SHRIVASTAVA, A , JHA, AK , (2015) NATURAL COMPOUNDS: ROLE IN REVERSAL OF EPIGENETIC CHANGES.BIOCHEMISTRY-MOSCOW. VOL. 80. ISSUE 8. P. 972 -989 | 25 | 17% | 1 |
7 | SHANKAR, E , KANWAL, R , CANDAMO, M , GUPTA, S , (2016) DIETARY PHYTOCHEMICALS AS EPIGENETIC MODIFIERS IN CANCER: PROMISE AND CHALLENGES.SEMINARS IN CANCER BIOLOGY. VOL. 40-41. ISSUE . P. 82 -99 | 28 | 12% | 3 |
8 | BOSVIEL, R , DURIF, J , DECHELOTTE, P , BIGNON, YJ , BERNARD-GALLON, D , (2012) EPIGENETIC MODULATION OF BRCA1 AND BRCA2 GENE EXPRESSION BY EQUOL IN BREAST CANCER CELL LINES.BRITISH JOURNAL OF NUTRITION. VOL. 108. ISSUE 7. P. 1187 -1193 | 14 | 26% | 10 |
9 | MEERAN, SM , AHMED, A , TOLLEFSBOL, TO , (2010) EPIGENETIC TARGETS OF BIOACTIVE DIETARY COMPONENTS FOR CANCER PREVENTION AND THERAPY.CLINICAL EPIGENETICS. VOL. 1. ISSUE . P. - | 21 | 14% | 80 |
10 | FRANK, J , VENTURELLI, S , BUSCH, C , BURKARD, M , LEISCHNER, C , LAUER, UM , (2015) EPIGENETIC ACTIVITIES OF FLAVONOIDS IN THE PREVENTION AND TREATMENT OF CANCER.CLINICAL EPIGENETICS. VOL. 7. ISSUE . P. - | 23 | 12% | 11 |
Classes with closest relation at Level 1 |